PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 5, 2022Molecules892 citationsOpen Access

Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches

MSMamello SekhoachaUniversity of the Free StateKRKeamogetswe RietCentral University of TechnologyPMPaballo MotloungCentral University of Technology

Key Points

Key points are not available for this paper at this time.

Abstract

Prostate cancer is one of the malignancies that affects men and significantly contributes to increased mortality rates in men globally. Patients affected with prostate cancer present with either a localized or advanced disease. In this review, we aim to provide a holistic overview of prostate cancer, including the diagnosis of the disease, mutations leading to the onset and progression of the disease, and treatment options. Prostate cancer diagnoses include a digital rectal examination, prostate-specific antigen analysis, and prostate biopsies. Mutations in certain genes are linked to the onset, progression, and metastasis of the cancer. Treatment for localized prostate cancer encompasses active surveillance, ablative radiotherapy, and radical prostatectomy. Men who relapse or present metastatic prostate cancer receive androgen deprivation therapy (ADT), salvage radiotherapy, and chemotherapy. Currently, available treatment options are more effective when used as combination therapy; however, despite available treatment options, prostate cancer remains to be incurable. There has been ongoing research on finding and identifying other treatment approaches such as the use of traditional medicine, the application of nanotechnologies, and gene therapy to combat prostate cancer, drug resistance, as well as to reduce the adverse effects that come with current treatment options. In this article, we summarize the genes involved in prostate cancer, available treatment options, and current research on alternative treatment options.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sekhoacha et al. (2022) studied this question.

synapsesocial.com/papers/69d6c7de639f29d8dcab3218https://doi.org/10.3390/molecules27175730
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics2022 · 95 citations
  2. 2Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: A pilot study in men with prostate cancer2009 · 102 citations
  3. 3Single-Therapy Androgen Suppression in Men with Advanced Prostate Cancer2000 · 397 citations
  4. 4A Polymorphism in the CDKN1B Gene Is Associated with Increased Risk of Hereditary Prostate Cancer2004 · 97 citations
  5. 5Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity2014 · 54 citations